Which statement is correct about adult transgender women who take feminizing hormones?
A. They will also desire facial feminization, genital and breast augmentation surgeries.
B. They do not require cancer screening associated with their sex assigned at birth.
C. They often delay starting hormones until later in life due to a lack of family/societal acceptance.
D. They experience similar rates of harassment, violence, and poverty as their cisgender peers.
C. Transgender women might choose to delay initiating feminizing hormone therapy due to a perceived lack of acceptance of their affirmed gender by family and friends. Timing of gender transition can be highly individualized. Healthcare providers should not assume the interest in transitioning started in adulthood due to a lack of interest or awareness during younger years.
A. Not all transgender women desire surgery, so these types of assumptions should not be made.
B. Cancer screening is based on the individual patient's cancer risk, which may or may not be related to their gender assigned at birth. Transgender women might need breast cancer screening if they have been receiving feminizing hormones, but will also need prostate cancer screening, since feminizing surgeries do not involve removal of the prostate.
D. According to survey research conducted by the National Center for Transgender Equality, transgender women experience harassment, violence, and poverty at a higher rate than cisgender women or cisgender men, especially if they are also a person of color.
Which statement about the diagnosis of gender dysphoria is correct?
A. It could facilitate access to treatment in some healthcare settings.
B. It is required for someone to be able to access gender-affirming hormone therapy.
C. It could apply to adults, but would not apply to children or adolescents.
D. It would apply to all patients with a transgender identity.
A. Many centers have moved towards an informed consent model for providing hormone therapy for transgender individuals; however, some settings and some reimbursement models require that patients have a diagnosis of gender dysphoria to be able to access transition-related care.
B. A diagnosis of gender dysphoria is no longer considered a requirement to access gender-affirming therapies
C. Gender dysphoria diagnostic criteria exist for adults, adolescents and children, although they differ slightly.
D. Many patients who seek gender-affirming therapies do not experience gender dysphoria, so it is not a universal experience of transgender individuals.